Clinical TrialsBridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... BridgeBio Unveils Strong Phase 3 Interim Data for BBP-418 in LGMD2I/R9 at M... Read Post »
Clinical TrialsBioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... BioMarin Presents New VOXZOGO Data Supporting Early Treatment in Achondropl... Read Post »
Clinical TrialsBiogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Biogen Initiates Phase 3 Program for Salanersen Following Promising Phase 1... Read Post »
Clinical TrialsAscletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Ascletis’ GLP-1 ASC30 Depot Injection Achieves Promising Phase 2 Results ... Read Post »
Clinical TrialsTelix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Telix Reports Positive Safety Results from Phase 3 ProstACT Global Trial of... Read Post »
Clinical TrialsVertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Vertex’s Povetacicept Cuts Proteinuria by 52% in Phase 3 RAINIER Interim ... Read Post »
Clinical TrialsAbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... AbbVie Reports Up to 9.8% Weight Loss in Phase 1 MAD Trial of Long-Acting A... Read Post »
Clinical TrialsRegeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Regeneron, Hansoh Report 19.3% Weight Loss with Dual GLP-1/GIP Drug Olatore... Read Post »
Clinical TrialsPfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Pfizer’s Trispecific Antibody Tilrekimig Shows Positive Phase 2 Results i... Read Post »
Clinical TrialsRoche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Roche Reports Phase 3 persevERA Setback for Giredestrant in Breast Cancer Read Post »
Clinical TrialsImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC ImmunityBio Files Updated ANKTIVA sBLA with FDA for Papillary NMIBC Read Post »
Clinical TrialsJOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study JOURNAVX Demonstrates High Opioid-Free Recovery Rate in Phase 4 Study Read Post »
Clinical TrialsHelus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Helus Pharma Reports Positive Phase 2 Results for HLP004 in GAD Read Post »
Clinical TrialsRoche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Roche’s Gazyva Shows Strong Phase III Success in Systemic Lupus: ALLEGORY... Read Post »
Clinical TrialsRoche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Roche’s Amylin Analog Petrelintide Delivers Up to 10.7% Weight Loss in Ph... Read Post »
Clinical TrialsFDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... FDA Places Partial Clinical Hold on PepGen’s FREEDOM2-DM1 Trial of PGN-ED... Read Post »
Clinical TrialsFibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers FibroBiologics Nears Trial Initiation for CYWC628 in Diabetic Foot Ulcers Read Post »
Clinical TrialsBiogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Biogen and Stoke Therapeutics Report Up to 91% Seizure Reduction with Zorev... Read Post »
Clinical TrialsAmpreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Ampreloxetine Misses Primary Endpoint in MSA-nOH CYPRESS Trial, Triggers Sa... Read Post »
Clinical TrialsIntellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Intellia Unveils Striking Long-Term Data on CRISPR Therapy Lonvo-z for Here... Read Post »
Clinical TrialsMerck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Merck, Eisai Advance Dual Oral Therapy with Strong Phase 3 RCC Data at ASCO... Read Post »
Clinical Trials55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... 55% Risk Reduction: Ralinepag’s ADVANCE OUTCOMES Results Signal New P... Read Post »
Clinical TrialsAbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... AbbVie’s SKYRIZI Shows Strong Induction Results in Hard-to-Treat Crohn’... Read Post »
Clinical TrialsMerck Reports Positive Phase 3 Results Across Ovarian, Bladder, and Renal C... Merck Reports Positive Phase 3 Results Across Ovarian, Bladder, and Renal C... Read Post »
Clinical TrialsSystImmune and BMS Report Dual PFS/OS Wins for Iza-Bren in Advanced TNBC Ph... SystImmune and BMS Report Dual PFS/OS Wins for Iza-Bren in Advanced TNBC Ph... Read Post »
Clinical TrialsOrganon Highlights VTAMA Family Sleep Benefits in ADORING Trials Organon Highlights VTAMA Family Sleep Benefits in ADORING Trials Read Post »
Clinical TrialsLilly’s Olumiant Shows Strong Hair Regrowth in Adolescents with Sever... Lilly’s Olumiant Shows Strong Hair Regrowth in Adolescents with Sever... Read Post »
Clinical TrialsBayer’s PEACE‑3 Phase III Trial Shows Enzalutamide Plus Radium‑223 Im... Bayer’s PEACE‑3 Phase III Trial Shows Enzalutamide Plus Radium‑223 Im... Read Post »
Clinical TrialsGalderma’s Nemluvio Shows Sustained Efficacy and Safety in Prurigo No... Galderma’s Nemluvio Shows Sustained Efficacy and Safety in Prurigo No... Read Post »
Clinical TrialsPalvella Announces Topline Win for QTORIN in Microcystic Lymphatic Malforma... Palvella Announces Topline Win for QTORIN in Microcystic Lymphatic Malforma... Read Post »
Clinical TrialsArgenx Reports Improved Ocular Symptoms in MG with Subcutaneous VYVGART Argenx Reports Improved Ocular Symptoms in MG with Subcutaneous VYVGART Read Post »
Clinical TrialsEli Lilly’s Orforglipron Outperforms Oral Semaglutide in ACHIEVE‑3 ... Eli Lilly’s Orforglipron Outperforms Oral Semaglutide in ACHIEVE‑3 ... Read Post »
Clinical TrialsViiV’s Lotivibart Hits 94% HIV Control at 12 Months EMBRACE Data ViiV’s Lotivibart Hits 94% HIV Control at 12 Months EMBRACE Data Read Post »
Clinical TrialsAxsome Therapeutics Doses First Patient in CLARITY Phase 3 Trial Axsome Therapeutics Doses First Patient in CLARITY Phase 3 Trial Read Post »
Clinical TrialsPromising Phase 3 Data for Merck’s Doravirine/Islatravir Combo in HIV Promising Phase 3 Data for Merck’s Doravirine/Islatravir Combo in HIV Read Post »
Clinical TrialsBristol Myers Squibb’s Reblozyl Shows Promise in Alpha-Thalassemia: P... Bristol Myers Squibb’s Reblozyl Shows Promise in Alpha-Thalassemia: P... Read Post »
Clinical TrialsNovartis RWE: Pluvicto Delivers 13.5-Month PFS in ARPI-Pre-Treated mCRPC Novartis RWE: Pluvicto Delivers 13.5-Month PFS in ARPI-Pre-Treated mCRPC Read Post »
Clinical TrialsNovo Nordisk-Backed Triple Agonist UBT251 Delivers Strong Phase 2 Results i... Novo Nordisk-Backed Triple Agonist UBT251 Delivers Strong Phase 2 Results i... Read Post »
Clinical TrialsMoonLake’s SLK Shows Strong Results in Phase 2 Trial for Axial Spondy... MoonLake’s SLK Shows Strong Results in Phase 2 Trial for Axial Spondy... Read Post »
Clinical TrialsGossamer Bio’s PROSERA Trial: Narrow Miss on 6MWD, Strong in Advanced... Gossamer Bio’s PROSERA Trial: Narrow Miss on 6MWD, Strong in Advanced... Read Post »
Clinical TrialsCagriSema Delivers 23% Weight Loss in REDEFINE 4: Strong Efficacy, Just Shy... CagriSema Delivers 23% Weight Loss in REDEFINE 4: Strong Efficacy, Just Shy... Read Post »
Clinical Trials Policy & AcquisitionsGilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Gilead Snaps Up Arcellx, Eyes Anito-cel Approval in Multiple Myeloma Read Post »
Clinical TrialsFrom Week 44 to 140: New TREMFYA® Evidence Reinforces Long-Term UC Control... From Week 44 to 140: New TREMFYA® Evidence Reinforces Long-Term UC Control... Read Post »
Clinical TrialsTakeda KEPLER Trial: Promising Vedolizumab Results for Pediatric Ulcerative... Takeda KEPLER Trial: Promising Vedolizumab Results for Pediatric Ulcerative... Read Post »
Clinical TrialsViiV Healthcare’s Cabenuva Demonstrates Superior Efficacy in LATITUDE... ViiV Healthcare’s Cabenuva Demonstrates Superior Efficacy in LATITUDE... Read Post »
Clinical TrialsMerck’s ENFLONSIA Shows Promising Safety in Second RSV Season for Hig... Merck’s ENFLONSIA Shows Promising Safety in Second RSV Season for Hig... Read Post »
Clinical TrialsPfizer Advances BRAFTOVI in Colorectal Cancer with New BREAKWATER Results Pfizer Advances BRAFTOVI in Colorectal Cancer with New BREAKWATER Results Read Post »
Clinical TrialsNovartis’ Remibrutinib Shows Promise in Chronic Inducible Urticaria Novartis’ Remibrutinib Shows Promise in Chronic Inducible Urticaria Read Post »
Clinical TrialsViiV Healthcare Highlights Lotivibart and Cabotegravir LA Findings at CROI ... ViiV Healthcare Highlights Lotivibart and Cabotegravir LA Findings at CROI ... Read Post »
Clinical TrialsOcular Therapeutix’s AXPAXLI Achieves Superiority in Wet AMD Phase 3 ... Ocular Therapeutix’s AXPAXLI Achieves Superiority in Wet AMD Phase 3 ... Read Post »
